Overview
The life sciences industry is characterized, in large part, by unending innovation driven by the constant demand for new medical therapies. It is equally characterized by a robust but evolving regulatory framework in which the development of new technologies tends to outpace the laws needed to govern them.
In such a dynamic environment dominated by compliance issues and enforcement concerns, savvy legal advice is essential to an organization’s success.
At Epstein Becker Green, we have a tight-knit team of life sciences attorneys and advisors with strong backgrounds in science, industry, and government. Our clients are often on the leading edge of new technologies, and they trust us to guide them in areas where the regulatory picture remains unclear. We help them understand the law and its practical implications so they can adopt workable approaches to their legal, regulatory, and business issues.
Navigating the Regulatory Landscape
In an industry where stringent compliance obligations accompany every facet of a product’s development and commercialization, few companies can navigate the regulatory landscape without help. Our clients look to us to devise an overall regulatory strategy for their product, and we work with them to decide how that strategy will be implemented. How and by whom will the therapy be used? What research will be needed? What claims will need substantiating? What reimbursement schemes make the most sense? The answers to such questions—and countless similar ones—form the basis of each application for regulatory approval and provide our clients with roadmaps for addressing compliance issues going forward.
Our deep understanding of the applicable regulatory bodies and their enforcement mechanisms is key to every aspect of our client service. We represent clients in front of all such bodies, both in routine matters and in investigative inquiries. Our lawyers advise them on the development of their manufacturing and distribution systems. We arrange contracts defining their relationships with customers, vendors, and payors. We review their pricing options and sign off on advertising and promotional communications. Each of these efforts—and much more—is designed to ensure that all operations are fully optimized from both a business and a regulatory standpoint.
Serving Our Clients
Our team of life sciences attorneys and advisors serves organizations across the length and breadth of the life sciences industry, including:
- Academic centers
- Artificial intelligence companies
- Biotechnology companies
- Clinical laboratories
- Combination product manufacturers
- Digital health (IoT) companies
- Food and Dietary Supplements
- Genetics and Genomics
- Human cellular and tissue products (HCT/P) manufacturers
- In vitro diagnostic innovators
- Investors in the life sciences industry
- Medical device manufacturers
- Pharmaceutical and biologic manufacturers
- Precision medicine laboratories
- Research institutions and investigators
- Research services vendors (including contract research organizations and site management organizations
- Suppliers and distributors
- Telehealth companies
- Trade associations and industry coalitions
We cover a broad scope of products and services that fall within these general categories: research and development, clinical research support, product commercialization, FDA regulatory strategy, compliance and training, litigation, and transactions and capitalization.
Read less
Focus Areas
Services
- Academic and Clinical Research
- ADA and Public Accommodations
- Affirmative Action/OFCCP Compliance
- Appellate
- Business Torts, Competition & Trade Secrets
- Class Actions
- Commercial and Contract Litigation
- Corporate & Transactional
- Corporate and Securities Litigation
- Corporate Compliance Program Development, Implementation, and Effectiveness
- Corporate Financing
- Corporate Governance
- Corporate Reorganization
- Cross-Border Data Transfers
- Cross-Border Transactions
- Cybersecurity Risk Assessment
- Data Asset Management
- Data Breach and Incident Response
- Data Breach/Cybersecurity Investigations & Litigation
- Data Protection
- DEI Compliance and Legal Counseling
- Dietary Supplement Litigation
- Digital Health
- Drug and Medical Device Coding, Coverage, and Payment
- Drug and Medical Device Distribution
- Drug and Medical Device Litigation
- Drug Pricing Policy & Reporting
- Employee Benefits and ERISA
- Employment Compliance Counseling
- Employment Litigation
- Employment Training
- Employment, Labor & Workforce Management
- ERISA – Retirement and Benefit Plan Litigation
- Executive Compensation
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Financial Restructuring and Bankruptcy
- Foreign Multinational Counseling and Litigation
- General Counsel Services
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Policy and Legislation
- Immigration
- Industry Research and Clinical Trials
- Insider Threats
- Intellectual Property
- Intellectual Property Litigation
- Internet of Things (IoT)
- Labor and Employment Due Diligence
- Labor Management Relations
- Life Sciences
- Life Sciences Due Diligence
- Litigation & Business Disputes
- Mergers, Acquisitions & Divestitures
- Occupational Safety and Health (OSHA)
- Pandemic Workforce Issues
- Pay Equity
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Real Estate
- Regulatory Strategy, Product Development, and Product Approvals
- Remote and Hybrid Work
- Social Media and the Workplace
- State Privacy Law Compliance
- Tax and Tax-Exempt Counseling
- Trade Secrets & Employee Mobility
- Wage and Hour
- Whistleblowing and Compliance
- White Collar Defense and Internal Investigations
- Workforce Government Relations
- Workforce Restructuring and Other Cost-Saving Mechanisms
- Workplace Investigations
Industries
Experience
Our Team
Media
Events
Past Events
- March 18 - 20, 2026
- February 11-13, 2026
Insights
Insights
- Media CoverageEpstein Becker Green Featured in Litigator of the Week Series2 minute read
- Media CoverageEpstein Becker Green Featured in Legal Lions of the Week Series2 minute read
- BlogsVideo: NLRB Shifts Enforcement, DOL’s Non-Union Focus, and EEOC’s DEI Crackdown - Employment Law This Week2 minute read
- Media Coverage
Media Covers Judge's Verdict in AAP v. Kennedy
7 minute read - Media CoverageElizabeth McEvoy Quoted in "China-Focused Bulk Data Rule Sparks New Risk for Pixel Tracking"3 minute read
- BlogsHHS OIG Issues Favorable Advisory Opinion Regarding Surgical Supply Discounts to Ambulatory Surgery Centers in Exchange ...5 minute read
- BlogsVideo: NLRB and DOL Take Action on Joint Employer and Independent Contractor Rules - Employment Law This Week2 minute read
- BlogsHealth Care Workplace Violence Legislation Heats Up in 20268 minute read
- Media CoverageAlan Arville Quoted in "A Look at the Real Impact of the FTC's PBM Settlements"2 minute read
- PublicationsWhen the Front Door Is an Algorithm: Guiding Consumer Use of AI in Health Care6 minute read
- PublicationsAnthem Sues HaloMD over Alleged No Surprises Act Arbitration Abuse5 minute read
- BlogsDOGE's Attempt to Crowdsource Medicaid Fraud Scrutiny: Is This the Future of Healthcare Fraud Investigations?4 minute read
- BlogsFeds vs. the States: Dr. Mehmet Oz Announces an Investigation Into New York’s Medicaid Program4 minute read
- PublicationsVaccine Litigation at the Brink: A Surge of Cases Threatens Public Health3 minute read
- BlogsU.S. Supreme Court to Weigh Induced Infringement Case Regarding ‘Generic Version of Vascepa®’8 minute read
- BlogsVideo: NYC Enforcement Blitz, CA Surveillance Pricing, and PA Criminal History Rule Update - Employment Law This Week2 minute read
- Media CoverageLorrin Melanson Quoted in "FDA Rare-Disease Guidance Brings Both Hope and Questions"3 minute read
- Media CoveragePaul DeCamp Quoted in “Labor Agency’s Gig Worker Flip-Flopping Weakens Rules in Court”2 minute read
- Firm AnnouncementsBob Mendes, Former Nashville City Chief Development Officer and Veteran Attorney, Joins Epstein Becker Green3 minute read
- Media CoverageBob Mendes Featured in “Mendes Moves from Metro to Law Firm”2 minute read
- Media CoverageMedia Covers Bob Mendes’s Move to Epstein Becker Green5 minute read
- PublicationsDiagnostic Imaging Interoperability RFI Shines a Spotlight on the Lack of Patient-Centered Longitudinal Health Records ...15 minute read
- PublicationsAI Use Will Drive Health Care and Life Sciences Investment7 minute read
- BlogsCloser Look at H.R. 7291: What the “GRAS Oversight and Transparency Act” Could Mean for Dietary Supplements ...6 minute read
- BlogsVideo: How to Respond to Employee Concerns About ICE Investigations - Employment Law This Week3 minute read
- BlogsDOJ Deputy Assistant Attorney General Addresses FCA Enforcement Priorities and Reinforces Commitment to Robust ...5 minute read
- Firm Announcements
Epstein Becker Green Attorneys Honored with 2026 JD Supra Readers’ Choice Awards for Notable Thought Leadership ...
2 minute read - BlogsInterested in Opening a Medical Spa? (Part III): Here’s (More) That You Need to Know10 minute read
- Media CoverageMedia Covers Leah Brownlee Taylor’s Move to Epstein Becker Green2 minute read
- PublicationsRecord FCA Recoveries Signal Intensified Healthcare Focus3 minute read
- PublicationsI Was a Moderna Exec When the Covid Vaccine Rolled Out. That Spirit of Possibility Is No More.4 minute read
- BlogsVideo: What Do Federal DEI Crackdowns Mean for Employers? - Employment Law This Week3 minute read
- BlogsIRS Issues Guidance Regarding Group Exemption Letters5 minute read
- Media CoverageJames Boiani Quoted in “US Could Take Action Including Fines Against Hims After Brief Wegovy Copy Launch”2 minute read
- Media CoverageLeah Brownlee Taylor Featured in "Epstein Becker Green Adds Acting GC of Marshals Service"4 minute read
- BlogsLegislative Push for FDA Preemptive Authority Over Dietary Supplement Regulation3 minute read
- Firm AnnouncementsEpstein Becker Green Welcomes DOJ Veteran Litigator Leah Brownlee Taylor in Washington, DC2 minute read
- PublicationsNJ Family Leave Act Expands Coverage Starting July 20266 minute read
- BlogsGUARD and GLOBE Pricing Models Could Test Manufacturer Rebates for Medicare Part B and D Drugs5 minute read
- BlogsVideo: DOL Compliance Tools & PBM Regulation, NLRB Intake Updates - Employment Law This Week2 minute read
- BlogsFDA’s Office of Dietary Supplement Programs Signals Key Enforcement and Policy Priorities for the Year Ahead4 minute read
- BlogsOIG Issues Guidance, Request for Information on DTC Programs7 minute read
- BlogsOIG Greenlights Cost-Sharing Waiver for Commercially Insured Patients7 minute read
- PublicationsAgency Backlog Can Slow a Deal, but It Doesn’t Have to Derail It2 minute read
- Media CoverageRobert Wanerman Quoted in "Inside HHS’ Anti-Fraud Efforts: An Aggressive Crackdown Sweeps Up Mainly Democratic-Led ...2 minute read
- Firm AnnouncementsVeteran Health System Transactional Attorney Ben Wilson Joins Epstein Becker Green3 minute read
- Media Coverage
Ben Wilson's Move from Ropes & Gray to Epstein Becker Green Featured in The American Lawyer
6 minute read - PublicationsSupporting Pharmacists to Provide Contraceptive Care2 minute read
- BlogsVideo: Remote Work and Disability Discrimination - What Employers Need to Know - Employment Law This Week3 minute read
- Firm AnnouncementsCorporate Transactional Attorney Kaci Hohmann Joins Epstein Becker Green in Portland2 minute read

